Regor to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
- Written by PR Newswire
CAMBRIDGE, Mass., June 5, 2024 /PRNewswire/ -- Regor Therapeutics Group, a clinical-stage global biopharmaceutical company, today announced the Company will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on Thursday, June 12. Dr. Xiayang Qiu, Founder and CEO, will represent the Company in a session scheduled at 11:20...
Read more: Regor to Present at the Goldman Sachs 45th Annual Global Healthcare Conference














